bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Fig. S1 from Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth
Authors: Yan Zhenwen , Zou Huafei , Tian Fang , Grandis Jennifer R. , Mixson A. James , Lu Patrick Y. , Li Lu-Yuan
Published: April 2023

Supplementary Fig. S1 from Human rhomboid family-1 gene silencing causes apoptosis or autophagy to epithelial cancer cells and inhibits xenograft tumor growth
Supplementary Figure Legends 1-4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
Authors: Sakai Ryo , Kagawa Shunsuke , Yamasaki Yasumoto , Kojima Toru , Uno Futoshi , Hashimoto Yuuri , Watanabe Yuichi , Urata Yasuo , Tanaka Noriaki , Fujiwara Toshiyoshi
Published: April 2023

Supplementary Figure Legends 1-4 from Preclinical Evaluation of Differentially Targeting Dual Virotherapy for Human Solid Cancer
Supplementary Fig. S1 from Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues
Authors: Benkoël Liliane , Bernard Jean-Paul , Payan-Defais Marie-José , Crescence Lydie , Franceschi Cécile , Delmas Mireille , Ouaissi Mehdi , Sastre Bernard , Sahel José , Benoliel Anne-Marie , Bongrand Pierre , Silvy Françoise , Gauthier Laurent , Romagné François , Lombardo Dominique , Mas Eric
Published: April 2023

Supplementary Fig. S1 from Monoclonal antibody 16D10 to the COOH-terminal domain of the feto-acinar pancreatic protein targets pancreatic neoplastic tissues
Supplementary Materials from Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database
Authors: Orina Josiah N. , Calcagno Anna Maria , Wu Chung-Pu , Varma Sudhir , Shih Joanna , Lin Min , Eichler Gabriel , Weinstein John N. , Pommier Yves , Ambudkar Suresh V. , Gottesman Michael M. , Gillet Jean-Pierre
Published: April 2023

Supplementary Materials from Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database
Supplementary Video 2 from Peroxisome Proliferator-Activated Receptor-γ Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition
Authors: Reka Ajaya Kumar , Kurapati Himabindu , Narala Venkata R. , Bommer Guido , Chen Jun , Standiford Theodore J. , Keshamouni Venkateshwar G.
Published: April 2023

Supplementary Video 2 from Peroxisome Proliferator-Activated Receptor-γ Activation Inhibits Tumor Metastasis by Antagonizing Smad3-Mediated Epithelial-Mesenchymal Transition
Supplementary Tables from Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800
Authors: Massey Andrew J. , Schoepfer Joseph , Brough Paul A. , Brueggen Josef , Chène Patrick , Drysdale Martin J. , Pfaar Ulrike , Radimerski Thomas , Ruetz Stephan , Schweitzer Alain , Wood Mike , Garcia-Echeverria Carlos , Jensen Michael Rugaard
Published: April 2023

Supplementary Tables from Preclinical Antitumor Activity of the Orally Available Heat Shock Protein 90 Inhibitor NVP-BEP800
Supplementary Table 1 from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin
Authors: Ceppi Paolo , Papotti Mauro , Monica Valentina , Iacono Marco Lo , Saviozzi Silvia , Pautasso Marisa , Novello Silvia , Mussino Stefano , Bracco Enrico , Volante Marco , Scagliotti Giorgio V.
Published: April 2023

Supplementary Table 1 from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin
Supplementary Figure 2 from Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination
Authors: Mordant Pierre , Loriot Yohann , Leteur Céline , Calderaro Julien , Bourhis Jean , Wislez Marie , Soria Jean-Charles , Deutsch Eric
Published: April 2023

Supplementary Figure 2 from Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination
Supplementary Figure and Table Legend from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin
Authors: Ceppi Paolo , Papotti Mauro , Monica Valentina , Iacono Marco Lo , Saviozzi Silvia , Pautasso Marisa , Novello Silvia , Mussino Stefano , Bracco Enrico , Volante Marco , Scagliotti Giorgio V.
Published: April 2023

Supplementary Figure and Table Legend from Effects of Src kinase inhibition induced by dasatinib in non–small cell lung cancer cell lines treated with cisplatin
Supplementary Figure 1 from Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination
Authors: Mordant Pierre , Loriot Yohann , Leteur Céline , Calderaro Julien , Bourhis Jean , Wislez Marie , Soria Jean-Charles , Deutsch Eric
Published: April 2023

Supplementary Figure 1 from Dependence on Phosphoinositide 3-Kinase and RAS-RAF Pathways Drive the Activity of RAF265, a Novel RAF/VEGFR2 Inhibitor, and RAD001 (Everolimus) in Combination
Supplementary Fig. S1 from Topoisomerase IIα-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin
Authors: Yan Tiandong , Deng Shiwei , Metzger Annegret , Gödtel-Armbrust Ute , Porter Andrew C.G. , Wojnowski Leszek
Published: April 2023

Supplementary Fig. S1 from Topoisomerase IIα-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin
Supplementary Tables from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma
Authors: Augustine Christina K. , Jung Sin-Ho , Sohn Insuk , Yoo Jin Soo , Yoshimoto Yasunori , Olson John A. , Friedman Henry S. , Ali-Osman Francis , Tyler Douglas S.
Published: April 2023

Supplementary Tables from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma
Supplementary Figure 4 from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma
Authors: Augustine Christina K. , Jung Sin-Ho , Sohn Insuk , Yoo Jin Soo , Yoshimoto Yasunori , Olson John A. , Friedman Henry S. , Ali-Osman Francis , Tyler Douglas S.
Published: April 2023

Supplementary Figure 4 from Gene Expression Signatures as a Guide to Treatment Strategies for In-Transit Metastatic Melanoma
Supplementary Fig. S3 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Authors: McGovern Ursula B. , Francis Richard E. , Peck Barrie , Guest Stephanie K. , Wang Jun , Myatt Stephen S. , Krol Janna , Kwok Jimmy M-M. , Polychronis Andreas , Coombes R. Charles , Lam Eric W-F.
Published: April 2023

Supplementary Fig. S3 from Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
Supplementary Figures 1-2 from Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells
Authors: Dorsey Jay F. , Mintz Akiva , Tian Xiaobing , Dowling Melissa L. , Plastaras John P. , Dicker David T. , Kao Gary D. , El-Deiry Wafik S.
Published: April 2023

Supplementary Figures 1-2 from Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) and paclitaxel have cooperative in vivo effects against glioblastoma multiforme cells
Supplementary Fig. from IKKβ-mediated nuclear factor-κB activation attenuates smac mimetic–induced apoptosis in cancer cells
Authors: Bai Lang , Chen Wenshu , Chen Wenjie , Wang Xia , Tang Hong , Lin Yong
Published: April 2023

Supplementary Fig. from IKKβ-mediated nuclear factor-κB activation attenuates smac mimetic–induced apoptosis in cancer cells
Supplementary Figure 7 from Multigene Expression–Based Predictors for Sensitivity to Vorinostat and Velcade in Non–Small Cell Lung Cancer
Authors: Nagji Alykhan S. , Cho Sang-Hoon , Liu Yuan , Lee Jae K. , Jones David R.
Published: April 2023

Supplementary Figure 7 from Multigene Expression–Based Predictors for Sensitivity to Vorinostat and Velcade in Non–Small Cell Lung Cancer
Supplementary Figure 6 from Multigene Expression–Based Predictors for Sensitivity to Vorinostat and Velcade in Non–Small Cell Lung Cancer
Authors: Nagji Alykhan S. , Cho Sang-Hoon , Liu Yuan , Lee Jae K. , Jones David R.
Published: April 2023

Supplementary Figure 6 from Multigene Expression–Based Predictors for Sensitivity to Vorinostat and Velcade in Non–Small Cell Lung Cancer
Supplementary Figure 5 from Multigene Expression–Based Predictors for Sensitivity to Vorinostat and Velcade in Non–Small Cell Lung Cancer
Authors: Nagji Alykhan S. , Cho Sang-Hoon , Liu Yuan , Lee Jae K. , Jones David R.
Published: April 2023

Supplementary Figure 5 from Multigene Expression–Based Predictors for Sensitivity to Vorinostat and Velcade in Non–Small Cell Lung Cancer
Supplementary Fig. S5 from The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt
Authors: Maksimovic-Ivanic Danijela , Mijatovic Sanja , Miljkovic Djordje , Harhaji-Trajkovic Ljubica , Timotijevic Gordana , Mojic Marija , Dabideen Darrin , Cheng Kai Fan , McCubrey James A. , Mangano Katia , Al-Abed Yousef , Libra Massimo , Garotta Gianni , Stosic-Grujicic Stanislava , Nicoletti Ferdinando
Published: April 2023

Supplementary Fig. S5 from The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt
Supplementary Fig. S4 from The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt
Authors: Maksimovic-Ivanic Danijela , Mijatovic Sanja , Miljkovic Djordje , Harhaji-Trajkovic Ljubica , Timotijevic Gordana , Mojic Marija , Dabideen Darrin , Cheng Kai Fan , McCubrey James A. , Mangano Katia , Al-Abed Yousef , Libra Massimo , Garotta Gianni , Stosic-Grujicic Stanislava , Nicoletti Ferdinando
Published: April 2023

Supplementary Fig. S4 from The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt
Supplementary Data from Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells
Authors: Beharry Zanna , Zemskova Marina , Mahajan Sandeep , Zhang Fengxue , Ma Jian , Xia Zuping , Lilly Michael , Smith Charles D. , Kraft Andrew S.
Published: April 2023

Supplementary Data from Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells
Supplementary Fig. S2 from The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt
Authors: Maksimovic-Ivanic Danijela , Mijatovic Sanja , Miljkovic Djordje , Harhaji-Trajkovic Ljubica , Timotijevic Gordana , Mojic Marija , Dabideen Darrin , Cheng Kai Fan , McCubrey James A. , Mangano Katia , Al-Abed Yousef , Libra Massimo , Garotta Gianni , Stosic-Grujicic Stanislava , Nicoletti Ferdinando
Published: April 2023

Supplementary Fig. S2 from The antitumor properties of a nontoxic, nitric oxide–modified version of saquinavir are independent of Akt
Supplementary Fig. S2 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer
Authors: Liu Dong , Kojima Toru , Ouchi Masaaki , Kuroda Shinji , Watanabe Yuichi , Hashimoto Yuuri , Onimatsu Hideki , Urata Yasuo , Fujiwara Toshiyoshi
Published: April 2023

Supplementary Fig. S2 from Preclinical evaluation of synergistic effect of telomerase-specific oncolytic virotherapy and gemcitabine for human lung cancer
Supplementary Fig. from Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
Authors: Zhai Dayong , Jin Chaofang , Shiau Chung-wai , Kitada Shinichi , Satterthwait Arnold C. , Reed John C.
Published: April 2023

Supplementary Fig. from Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins
Supplementary Table 2 from Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells
Authors: Moiseeva Elena P. , Almeida Gabriela M. , Jones George D.D. , Manson Margaret M.
Published: April 2023

DOC file, 112KB, Enzymes involved in DNA and chromatin folding, which are targeted by dietary agents.
Supplementary Table 1 from Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
Authors: Nagaraj Nagathihalli S. , Smith J. Joshua , Revetta Frank , Washington M. Kay , Merchant Nipun B.
Published: April 2023

Supplementary Table 1 from Targeted Inhibition of Src Kinase Signaling Attenuates Pancreatic Tumorigenesis
Supplementary Fig. S1 from Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinib
Authors: Wang Shining , Zhou Qingyu , Gallo James M.
Published: April 2023

Supplementary Fig. S1 from Demonstration of the equivalent pharmacokinetic/pharmacodynamic dosing strategy in a multiple-dose study of gefitinib
Supplementary Table S2 from Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo
Authors: Kortenhorst Madeleine S.Q. , Isharwal Sumit , van Diest Paul J. , Chowdhury Wasim H. , Marlow Cameron , Carducci Michael A. , Rodriguez Ronald , Veltri Robert W.
Published: April 2023

Supplementary Table S2 from Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo
Supplementary Figure 2 from Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation
Authors: Lagas Jurjen S. , van Waterschoot Robert A.B. , Sparidans Rolf W. , Wagenaar Els , Beijnen Jos H. , Schinkel Alfred H.
Published: April 2023

Supplementary Figure 2 from Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation
Supplementary Tables 1-3, Figures 1-4 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Authors: Buchanan Sean G. , Hendle Jorg , Lee Patrick S. , Smith Christopher R. , Bounaud Pierre-Yves , Jessen Katti A. , Tang Crystal M. , Huser Nanni H. , Felce Jeremy D. , Froning Karen J. , Peterman Marshall C. , Aubol Brandon E. , Gessert Steve F. , Sauder J. Michael , Schwinn Kenneth D. , Russell Marijane , Rooney Isabelle A. , Adams Jason , Leon Barbara C. , Do Tuan H. , Blaney Jeff M. , Sprengeler Paul A. , Thompson Devon A. , Smyth Lydia , Pelletier Laura A. , Atwell Shane , Holme Kevin , Wasserman Stephen R. , Emtage Spencer , Burley Stephen K. , Reich Siegfried H.
Published: April 2023

Supplementary Tables 1-3, Figures 1-4 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Supplementary Figure 1 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Authors: Buchanan Sean G. , Hendle Jorg , Lee Patrick S. , Smith Christopher R. , Bounaud Pierre-Yves , Jessen Katti A. , Tang Crystal M. , Huser Nanni H. , Felce Jeremy D. , Froning Karen J. , Peterman Marshall C. , Aubol Brandon E. , Gessert Steve F. , Sauder J. Michael , Schwinn Kenneth D. , Russell Marijane , Rooney Isabelle A. , Adams Jason , Leon Barbara C. , Do Tuan H. , Blaney Jeff M. , Sprengeler Paul A. , Thompson Devon A. , Smyth Lydia , Pelletier Laura A. , Atwell Shane , Holme Kevin , Wasserman Stephen R. , Emtage Spencer , Burley Stephen K. , Reich Siegfried H.
Published: April 2023

Supplementary Figure 1 from SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Supplementary Fig. S2 from SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule–mediated nuclear factor-κB activation, c-Fos/c-Jun expression, and cellular apoptosis
Authors: Farhana Lulu , Dawson Marcia I. , Xu Liping , Dannenberg Jan-Hermen , Fontana Joseph A.
Published: April 2023

Supplementary Fig. S2 from SHP and Sin3A expression are essential for adamantyl-substituted retinoid-related molecule–mediated nuclear factor-κB activation, c-Fos/c-Jun expression, and cellular apoptosis
Supplementary Fig. S4 from A selective small-molecule nuclear factor-κB inhibitor from a high-throughput cell-based assay for “activator protein-1 hits”
Authors: Kang Moon-Il , Henrich Curtis J. , Bokesch Heidi R. , Gustafson Kirk R. , McMahon James B. , Baker Alyson R. , Young Matthew R. , Colburn Nancy H.
Published: April 2023

Supplementary Fig. S4 from A selective small-molecule nuclear factor-κB inhibitor from a high-throughput cell-based assay for “activator protein-1 hits”
Supplementary Tables 1-2 from The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo
Authors: Martin Lesley-Ann , Head Julia E. , Pancholi Sunil , Salter Janine , Quinn Emma , Detre Simone , Kaye Stan , Howes Angela , Dowsett Mitch , Johnston Stephen R.D.
Published: April 2023

PDF file - 52K
Supplementary Figure Legend from The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression in vitro and in vivo
Authors: Martin Lesley-Ann , Head Julia E. , Pancholi Sunil , Salter Janine , Quinn Emma , Detre Simone , Kaye Stan , Howes Angela , Dowsett Mitch , Johnston Stephen R.D.
Published: April 2023

PDF file - 51K
Adobe PDF - Supplementary_Data.pdf from Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor
Authors: Mallon Robert , Hollander Irwin , Feldberg Larry , Lucas Judy , Soloveva Veronica , Venkatesan Aranapakam , Dehnhardt Christoph , Delos Santos Efren , Chen Zecheng , dos Santos Osvaldo , Ayral-Kaloustian Semiramis , Gibbons Jay
Published: April 2023

Adobe PDF - Supplementary_Data.pdf from Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor
Supplementary Fig. S1 from MicroRNA expression profiles for the NCI-60 cancer cell panel
Authors: Blower Paul E. , Verducci Joseph S. , Lin Shili , Zhou Jin , Chung Ji-Hyun , Dai Zunyan , Liu Chang-Gong , Reinhold William , Lorenzi Philip L. , Kaldjian Eric P. , Croce Carlo M. , Weinstein John N. , Sadee Wolfgang
Published: April 2023

Supplementary Fig. S1 from MicroRNA expression profiles for the NCI-60 cancer cell panel
Supplementary Data from Enhanced Anticancer Effect of the Combination of BIBW2992 and Thymidylate Synthase–Targeted Agents in Non–Small Cell Lung Cancer with the T790M Mutation of Epidermal Growth Factor Receptor
Authors: Takezawa Ken , Okamoto Isamu , Tanizaki Junko , Kuwata Kiyoko , Yamaguchi Haruka , Fukuoka Masahiro , Nishio Kazuto , Nakagawa Kazuhiko
Published: April 2023

Supplementary Data from Enhanced Anticancer Effect of the Combination of BIBW2992 and Thymidylate Synthase–Targeted Agents in Non–Small Cell Lung Cancer with the T790M Mutation of Epidermal Growth Factor Receptor
Supplementary Form 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Authors: Melnik Marianne K. , Webb Craig P. , Richardson Patrick J. , Luttenton Charles R. , Campbell Alan D. , Monroe Thomas J. , O'Rourke Timothy J. , Yost Kathleen J. , Szczepanek Connie M. , Bassett Michelle R. , Truszkowski Kimberly J. , Stein Phyllis , Van Brocklin Matthew W. , Davis Alan T. , Bedolla Gabriela , Vande Woude George F. , Koo Han-Mo
Published: April 2023

Supplementary Form 1 from Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Supplementary Data from Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Authors: Horton Terzah M. , Jenkins Gaye , Pati Debananda , Zhang Linna , Dolan M. Eileen , Ribes-Zamora Albert , Bertuch Alison A. , Blaney Susan M. , Delaney Shannon L. , Hegde Madhuri , Berg Stacey L.
Published: April 2023

Supplementary Data from Poly(ADP-ribose) polymerase inhibitor ABT-888 potentiates the cytotoxic activity of temozolomide in leukemia cells: influence of mismatch repair status and O6-methylguanine-DNA methyltransferase activity
Supplementary Table 1, Figure Legends 1-6 from A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
Authors: Brown Jeffrey L. , Cao Z. Alexander , Pinzon-Ortiz Maria , Kendrew Jane , Reimer Corinne , Wen Shenghua , Zhou Joe Q. , Tabrizi Mohammad , Emery Steve , McDermott Brenda , Pablo Lourdes , McCoon Patricia , Bedian Vahe , Blakey David C.
Published: April 2023

Supplementary Table 1, Figure Legends 1-6 from A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
Supplementary Figures 1-6 from A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
Authors: Brown Jeffrey L. , Cao Z. Alexander , Pinzon-Ortiz Maria , Kendrew Jane , Reimer Corinne , Wen Shenghua , Zhou Joe Q. , Tabrizi Mohammad , Emery Steve , McDermott Brenda , Pablo Lourdes , McCoon Patricia , Bedian Vahe , Blakey David C.
Published: April 2023

Supplementary Figures 1-6 from A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models
Supplementary Data from A novel hTERT promoter–driven E1A therapeutic for ovarian cancer
Authors: Xie Xiaoming , Hsu Jennifer L. , Choi Min-Gew , Xia Weiya , Yamaguchi Hirohito , Chen Chun-Te , Trinh Bon Q. , Lu Zhen , Ueno Naoto T. , Wolf Judith K. , Bast Robert C. , Hung Mien-Chie
Published: April 2023

Supplementary Data from A novel hTERT promoter–driven E1A therapeutic for ovarian cancer
Supplementary Figure 1 from BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Authors: Carboni Joan M. , Wittman Mark , Yang Zheng , Lee Francis , Greer Ann , Hurlburt Warren , Hillerman Stephen , Cao Carolyn , Cantor Glenn H. , Dell-John Janet , Chen Cliff , Discenza Lorell , Menard Krista , Li Aixin , Trainor George , Vyas Dolatrai , Kramer Robert , Attar Ricardo M. , Gottardis Marco M.
Published: April 2023

Supplementary Figure 1 from BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
Supplementary Figure 1 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
Authors: Bruzzese Francesca , Rocco Monia , Castelli Silvia , Di Gennaro Elena , Desideri Alessandro , Budillon Alfredo
Published: April 2023

Supplementary Figure 1 from Synergistic antitumor effect between vorinostat and topotecan in small cell lung cancer cells is mediated by generation of reactive oxygen species and DNA damage-induced apoptosis
Supplementary Table 1 from A Fully Human Insulin-Like Growth Factor-I Receptor Antibody SCH 717454 (Robatumumab) Has Antitumor Activity as a Single Agent and in Combination with Cytotoxics in Pediatric Tumor Xenografts
Authors: Wang Yaolin , Lipari Philip , Wang Xiaoying , Hailey Judith , Liang Lianzhu , Ramos Robert , Liu Ming , Pachter Jonathan A. , Bishop W. Robert , Wang Yan
Published: April 2023

Supplementary Table 1 from A Fully Human Insulin-Like Growth Factor-I Receptor Antibody SCH 717454 (Robatumumab) Has Antitumor Activity as a Single Agent and in Combination with Cytotoxics in Pediatric Tumor Xenografts
Supplementary Data from Architectonics of Phage-Liposome Nanowebs as Optimized Photosensitizer Vehicles for Photodynamic Cancer Therapy
Authors: Kalarical Janardhanan Sreeram , Narayan Shoba , Abbineni Gopal , Hayhurst Andrew , Mao Chuanbin
Published: April 2023

Supplementary Data from Architectonics of Phage-Liposome Nanowebs as Optimized Photosensitizer Vehicles for Photodynamic Cancer Therapy
Supplementary Fig. S2 from Recombinant, refolded tetrameric p53 and gonadotropin-releasing hormone-p53 slow proliferation and induce apoptosis in p53-deficient cancer cells
Authors: LaFevre-Bernt Michelle , Wu Shili , Lin Xinli
Published: April 2023

Supplementary Fig. S2 from Recombinant, refolded tetrameric p53 and gonadotropin-releasing hormone-p53 slow proliferation and induce apoptosis in p53-deficient cancer cells
Supplementary Fig. S1 from Silibinin inhibits translation initiation: implications for anticancer therapy
Authors: Lin Chen-Ju , Sukarieh Rami , Pelletier Jerry
Published: April 2023

Supplementary Fig. S1 from Silibinin inhibits translation initiation: implications for anticancer therapy
Supplementary Data from Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma
Authors: Siegelin Markus D. , Plescia Janet , Raskett Christopher M. , Gilbert Candace A. , Ross Alonzo H. , Altieri Dario C.
Published: April 2023

Supplementary Data from Global Targeting of Subcellular Heat Shock Protein-90 Networks for Therapy of Glioblastoma
Supplementary Data from Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo
Authors: Idris Aymen I. , Libouban Hélène , Nyangoga Hervé , Landao-Bassonga Euphemie , Chappard Daniel , Ralston Stuart H.
Published: April 2023

Supplementary Data from Pharmacologic inhibitors of IκB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo
Supplementary Figures 1-2 from AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
Authors: Davies Barry R. , Logie Armelle , McKay Jennifer S. , Martin Paul , Steele Samantha , Jenkins Richard , Cockerill Mark , Cartlidge Sue , Smith Paul D.
Published: April 2023

PDF file - 18K
Supplementary Data from Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo: Therapeutic Implications
Authors: Pham Lan V. , Tamayo Archito T. , Li Changping , Bornmann William , Priebe Waldemar , Ford Richard J.
Published: April 2023

Supplementary Data from Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo: Therapeutic Implications
Supplementary Data from Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study
Authors: Locatelli Giuseppe , Bosotti Roberta , Ciomei Marina , Brasca Maria G. , Calogero Raffaele , Mercurio Ciro , Fiorentini Francesco , Bertolotti Matteo , Scacheri Emanuela , Scaburri Angela , Galvani Arturo , Pesenti Enrico , De Baere Thierry , Soria Jean-Charles , Lazar Vladimir , Isacchi Antonella
Published: April 2023

Supplementary Data from Transcriptional Analysis of an E2F Gene Signature as a Biomarker of Activity of the Cyclin-Dependent Kinase Inhibitor PHA-793887 in Tumor and Skin Biopsies from a Phase I Clinical Study
Video Legends.Supplementary Table 1. Supplementary Figure 5 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
Authors: Pasquier Eddy , Sinnappan Snega , Munoz Marcia A. , Kavallaris Maria
Published: April 2023

Video Legends.Supplementary Table 1. Supplementary Figure 5 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
Supplementary Video 4 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
Authors: Pasquier Eddy , Sinnappan Snega , Munoz Marcia A. , Kavallaris Maria
Published: April 2023

Large File
Supplementary Video 3 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
Authors: Pasquier Eddy , Sinnappan Snega , Munoz Marcia A. , Kavallaris Maria
Published: April 2023

Large Fule
Supplementary Video 1 from ENMD-1198, a New Analogue of 2-Methoxyestradiol, Displays Both Antiangiogenic and Vascular-Disrupting Properties
Authors: Pasquier Eddy , Sinnappan Snega , Munoz Marcia A. , Kavallaris Maria
Published: April 2023

Large File
Supplementary Methods, Legends for Figures 1-5 from Improved low molecular weight Myc-Max inhibitors
Authors: Wang Huabo , Hammoudeh Dalia I. , Follis Ariele Viacava , Reese Brian E. , Lazo John S. , Metallo Steven J. , Prochownik Edward V.
Published: April 2023

Supplementary Methods, Legends for Figures 1-5 from Improved low molecular weight Myc-Max inhibitors
Supplementary Figure 5 from Improved low molecular weight Myc-Max inhibitors
Authors: Wang Huabo , Hammoudeh Dalia I. , Follis Ariele Viacava , Reese Brian E. , Lazo John S. , Metallo Steven J. , Prochownik Edward V.
Published: April 2023

Supplementary Figure 5 from Improved low molecular weight Myc-Max inhibitors
Supplementary Movie S1 from Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint
Authors: Chin Gregory M. , Herbst Ronald
Published: April 2023

Luciferase siRNA
Supplementary Fig. S4C from Antitumor activity of a membrane lytic peptide cyclized with a linker sensitive to membrane type 1-matrix metalloproteinase
Authors: Zhong Jieying , Chau Ying
Published: April 2023

Supplementary Fig. S4C from Antitumor activity of a membrane lytic peptide cyclized with a linker sensitive to membrane type 1-matrix metalloproteinase
Supplementary Data from In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I
Authors: Lu Jie , Chan Lai , Fiji Hannah D.G. , Dahl Russell , Kwon Ohyun , Tamanoi Fuyuhiko
Published: April 2023

Supplementary Data from In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase-I
Supplementary Fig. S2 from Antitumor activity of a membrane lytic peptide cyclized with a linker sensitive to membrane type 1-matrix metalloproteinase
Authors: Zhong Jieying , Chau Ying
Published: April 2023

Supplementary Fig. S2 from Antitumor activity of a membrane lytic peptide cyclized with a linker sensitive to membrane type 1-matrix metalloproteinase
Supplementary Figure 3 from Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice
Authors: Schaffer Beverly S. , Grayson Marcia H. , Wortham Joy M. , Kubicek Courtney B. , McCleish Amanda T. , Prajapati Suresh I. , Nelon Laura D. , Brady Michelle M. , Jung Inkyung , Hosoyama Tohru , Sarro Leslea M. , Hanes Martha A. , Rubin Brian P. , Michalek Joel E. , Clifford Charles B. , Infante Anthony J. , Keller Charles
Published: April 2023

Supplementary Figure 3 from Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice
Supplementary Figure 2 from Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice
Authors: Schaffer Beverly S. , Grayson Marcia H. , Wortham Joy M. , Kubicek Courtney B. , McCleish Amanda T. , Prajapati Suresh I. , Nelon Laura D. , Brady Michelle M. , Jung Inkyung , Hosoyama Tohru , Sarro Leslea M. , Hanes Martha A. , Rubin Brian P. , Michalek Joel E. , Clifford Charles B. , Infante Anthony J. , Keller Charles
Published: April 2023

Supplementary Figure 2 from Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice
Supplementary Figure 1 from Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice
Authors: Schaffer Beverly S. , Grayson Marcia H. , Wortham Joy M. , Kubicek Courtney B. , McCleish Amanda T. , Prajapati Suresh I. , Nelon Laura D. , Brady Michelle M. , Jung Inkyung , Hosoyama Tohru , Sarro Leslea M. , Hanes Martha A. , Rubin Brian P. , Michalek Joel E. , Clifford Charles B. , Infante Anthony J. , Keller Charles
Published: April 2023

Supplementary Figure 1 from Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice
Supplementary Data Legends from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Authors: Ragusa Marco , Majorana Alessandra , Statello Luisa , Maugeri Marco , Salito Loredana , Barbagallo Davide , Guglielmino Maria Rosa , Duro Laura R. , Angelica Rosario , Caltabiano Rosario , Biondi Antonio , Di Vita Maria , Privitera Giuseppe , Scalia Marina , Cappellani Alessandro , Vasquez Enrico , Lanzafame Salvatore , Basile Francesco , Di Pietro Cinzia , Purrello Michele
Published: April 2023

Supplementary Data Legends from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Supplementary Table S2 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Authors: Agarwal Anika , Covic Lidija , Sevigny Leila M. , Kaneider Nicole C. , Lazarides Katherine , Azabdaftari Gissou , Sharifi Sheida , Kuliopulos Athan
Published: April 2023

Supplementary Table S2 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Supplementary Data 6 from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Authors: Ragusa Marco , Majorana Alessandra , Statello Luisa , Maugeri Marco , Salito Loredana , Barbagallo Davide , Guglielmino Maria Rosa , Duro Laura R. , Angelica Rosario , Caltabiano Rosario , Biondi Antonio , Di Vita Maria , Privitera Giuseppe , Scalia Marina , Cappellani Alessandro , Vasquez Enrico , Lanzafame Salvatore , Basile Francesco , Di Pietro Cinzia , Purrello Michele
Published: April 2023

Supplementary Data 6 from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Supplementary Table S1 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Authors: Agarwal Anika , Covic Lidija , Sevigny Leila M. , Kaneider Nicole C. , Lazarides Katherine , Azabdaftari Gissou , Sharifi Sheida , Kuliopulos Athan
Published: April 2023

Supplementary Table S1 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Supplementary Fig. S4 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Authors: Agarwal Anika , Covic Lidija , Sevigny Leila M. , Kaneider Nicole C. , Lazarides Katherine , Azabdaftari Gissou , Sharifi Sheida , Kuliopulos Athan
Published: April 2023

Supplementary Fig. S4 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Supplementary Data 4 from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Authors: Ragusa Marco , Majorana Alessandra , Statello Luisa , Maugeri Marco , Salito Loredana , Barbagallo Davide , Guglielmino Maria Rosa , Duro Laura R. , Angelica Rosario , Caltabiano Rosario , Biondi Antonio , Di Vita Maria , Privitera Giuseppe , Scalia Marina , Cappellani Alessandro , Vasquez Enrico , Lanzafame Salvatore , Basile Francesco , Di Pietro Cinzia , Purrello Michele
Published: April 2023

Supplementary Data 4 from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Supplementary Fig. S2 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Authors: Agarwal Anika , Covic Lidija , Sevigny Leila M. , Kaneider Nicole C. , Lazarides Katherine , Azabdaftari Gissou , Sharifi Sheida , Kuliopulos Athan
Published: April 2023

Supplementary Fig. S2 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Supplementary Data 2 from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Authors: Ragusa Marco , Majorana Alessandra , Statello Luisa , Maugeri Marco , Salito Loredana , Barbagallo Davide , Guglielmino Maria Rosa , Duro Laura R. , Angelica Rosario , Caltabiano Rosario , Biondi Antonio , Di Vita Maria , Privitera Giuseppe , Scalia Marina , Cappellani Alessandro , Vasquez Enrico , Lanzafame Salvatore , Basile Francesco , Di Pietro Cinzia , Purrello Michele
Published: April 2023

Supplementary Data 2 from Specific Alterations of MicroRNA Transcriptome and Global Network Structure in Colorectal Carcinoma after Cetuximab Treatment
Supplementary Fig. S1 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Authors: Agarwal Anika , Covic Lidija , Sevigny Leila M. , Kaneider Nicole C. , Lazarides Katherine , Azabdaftari Gissou , Sharifi Sheida , Kuliopulos Athan
Published: April 2023

Supplementary Fig. S1 from Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
Supplementary Data from Silencing of Integrated Human Papillomavirus-16 Oncogenes by Small Interfering RNA–Mediated Heterochromatization
Authors: Palanichamy Jayanth Kumar , Mehndiratta Mohit , Bhagat Mohita , Ramalingam Pradeep , Das Brati , Das Prerna , Sinha Subrata , Chattopadhyay Parthaprasad
Published: April 2023

Supplementary Data from Silencing of Integrated Human Papillomavirus-16 Oncogenes by Small Interfering RNA–Mediated Heterochromatization
Supplementary Video 1 from Real-time Fluorescent Resonance Energy Transfer Analysis to Monitor Drug Resistance in Chronic Myelogenous Leukemia
Authors: Tunceroglu Ahmet , Matsuda Michiyuki , Birge Raymond B.
Published: April 2023

Supplementary Video 1 from Real-time Fluorescent Resonance Energy Transfer Analysis to Monitor Drug Resistance in Chronic Myelogenous Leukemia
Supplementary Figure Legends from Real-time Fluorescent Resonance Energy Transfer Analysis to Monitor Drug Resistance in Chronic Myelogenous Leukemia
Authors: Tunceroglu Ahmet , Matsuda Michiyuki , Birge Raymond B.
Published: April 2023

Supplementary Figure Legends from Real-time Fluorescent Resonance Energy Transfer Analysis to Monitor Drug Resistance in Chronic Myelogenous Leukemia
Supplementary Figure 1 from Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Authors: Degenhardt Yan , Greshock Joel , Laquerre Sylvie , Gilmartin Aidan G. , Jing Junping , Richter Mark , Zhang Xiping , Bleam Maureen , Halsey Wendy , Hughes Ashley , Moy Christopher , Liu-Sullivan Nancy , Powers Scott , Bachman Kurtis , Jackson Jeffrey , Weber Barbara , Wooster Richard
Published: April 2023

Supplementary Figure 1 from Sensitivity of Cancer Cells to Plk1 Inhibitor GSK461364A Is Associated with Loss of p53 Function and Chromosome Instability
Supplementary Table 1 from Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma
Authors: Koomoa Dana-Lynn T. , Borsics Tamas , Feith David J. , Coleman Craig C. , Wallick Christopher J. , Gamper Ivonne , Pegg Anthony E. , Bachmann André S.
Published: April 2023

Supplementary Table 1 from Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma
Supplementary Figure 1 from Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma
Authors: Koomoa Dana-Lynn T. , Borsics Tamas , Feith David J. , Coleman Craig C. , Wallick Christopher J. , Gamper Ivonne , Pegg Anthony E. , Bachmann André S.
Published: April 2023

Supplementary Figure 1 from Inhibition of S-adenosylmethionine decarboxylase by inhibitor SAM486A connects polyamine metabolism with p53-Mdm2-Akt/protein kinase B regulation and apoptosis in neuroblastoma
Supplementary Figure 1 from Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
Authors: Okamoto Isamu , Kaneda Hiroyasu , Satoh Taroh , Okamoto Wataru , Miyazaki Masaki , Morinaga Ryotaro , Ueda Shinya , Terashima Masaaki , Tsuya Asuka , Sarashina Akiko , Konishi Koichi , Arao Tokuzo , Nishio Kazuto , Kaiser Rolf , Nakagawa Kazuhiko
Published: April 2023

Supplementary Figure 1 from Phase I Safety, Pharmacokinetic, and Biomarker Study of BIBF 1120, an Oral Triple Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
Supplementary Table from The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel
Authors: Goldblatt Erin M. , Gentry Erin R. , Fox Melanie J. , Gryaznov Sergei M. , Shen Changyu , Herbert Brittney-Shea
Published: April 2023

Supplementary Table from The telomerase template antagonist GRN163L alters MDA-MB-231 breast cancer cell morphology, inhibits growth, and augments the effects of paclitaxel
Supplementary Data from Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
Authors: Park Margaret A. , Reinehr Roland , Häussinger Dieter , Voelkel-Johnson Christina , Ogretmen Besim , Yacoub Adly , Grant Steven , Dent Paul
Published: April 2023

Supplementary Data from Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells
Supplementary Materials from Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
Authors: Pfister Thomas D. , Reinhold William C. , Agama Keli , Gupta Shalu , Khin Sonny A. , Kinders Robert J. , Parchment Ralph E. , Tomaszewski Joseph E. , Doroshow James H. , Pommier Yves
Published: April 2023

Supplementary Materials from Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity
Supplementary Figure 5 from Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Authors: Okamoto Takashi , Inozume Takashi , Mitsui Hiroshi , Kanzaki Mirei , Harada Kazutoshi , Shibagaki Naotaka , Shimada Shinji
Published: April 2023

Supplementary Figure 5 from Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Supplementary Figure 4 from Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Authors: Okamoto Takashi , Inozume Takashi , Mitsui Hiroshi , Kanzaki Mirei , Harada Kazutoshi , Shibagaki Naotaka , Shimada Shinji
Published: April 2023

Supplementary Figure 4 from Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Supplementary Figure 2 from Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Authors: Okamoto Takashi , Inozume Takashi , Mitsui Hiroshi , Kanzaki Mirei , Harada Kazutoshi , Shibagaki Naotaka , Shimada Shinji
Published: April 2023

Supplementary Figure 2 from Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Supplementary Figure 1 from Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout
Authors: Versele Matthias , Talloen Willem , Rockx Cindy , Geerts Tamara , Janssen Boud , Lavrijssen Tom , King Peter , Göhlmann Hinrich W.H. , Page Martin , Perera Tim
Published: April 2023

Supplementary Figure 1 from Response prediction to a multitargeted kinase inhibitor in cancer cell lines and xenograft tumors using high-content tyrosine peptide arrays with a kinetic readout
Supplementary Fig. S5 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Authors: Mosley Jonathan D. , Poirier John T. , Seachrist Darcie D. , Landis Melissa D. , Keri Ruth A.
Published: April 2023

Supplementary Fig. S5 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Supplementary Fig. S4 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Authors: Mosley Jonathan D. , Poirier John T. , Seachrist Darcie D. , Landis Melissa D. , Keri Ruth A.
Published: April 2023

Supplementary Fig. S4 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Supplementary Data from Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin–inducer peptides
Authors: Obeid Michel
Published: April 2023

Supplementary Data from Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin–inducer peptides
Supplementary Fig. S3 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Authors: Mosley Jonathan D. , Poirier John T. , Seachrist Darcie D. , Landis Melissa D. , Keri Ruth A.
Published: April 2023

Supplementary Fig. S3 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Supplementary Tables 1-2 from Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines
Authors: Tahir Stephen K. , Wass John , Joseph Mary K. , Devanarayan Viswanath , Hessler Paul , Zhang Haichao , Elmore Steve W. , Kroeger Paul E. , Tse Christin , Rosenberg Saul H. , Anderson Mark G.
Published: April 2023

Supplementary Tables 1-2 from Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines
Supplementary Fig. S2 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Authors: Mosley Jonathan D. , Poirier John T. , Seachrist Darcie D. , Landis Melissa D. , Keri Ruth A.
Published: April 2023

Supplementary Fig. S2 from Rapamycin inhibits multiple stages of c-Neu/ErbB2–induced tumor progression in a transgenic mouse model of HER2-positive breast cancer
Supplementary Figure 1 from An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells
Authors: Kwong Joseph , Kulbe Hagen , Wong Donald , Chakravarty Probir , Balkwill Fran
Published: April 2023

Supplementary Figure 1 from An antagonist of the chemokine receptor CXCR4 induces mitotic catastrophe in ovarian cancer cells